AR

Amol Rajendra Bawake

Active Director Director DIN 10279932
DIN 10279932 First appointment Aug 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amol Rajendra Bawake

Data last updated:

Amol Rajendra Bawake is a Director at Carezie Pharma Private Limited (since 2023). The company operates in Paper.

DIN 10279932
Primary Designation Director
Industry Paper
First Appointment 16 Aug 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carezie Pharma Private Limited U21001PN2023PTC223161
Director16 Aug 20232023Active

Board colleagues of Amol Rajendra Bawake

NameDINCompanyDesignation
Vaishnavi Vijay Kolase10279933Carezie Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Carezie Pharma Private Limited
Premium access

Shareholding and investment profile for Amol Rajendra Bawake

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amol Rajendra Bawake

Amol Rajendra Bawake currently holds 1 directorship: Carezie Pharma Private Limited (Director, since 16 Aug 2023).

Amol Rajendra Bawake was first appointed on 16 Aug 2023 as Director at Carezie Pharma Private Limited.

The current boards of Amol Rajendra Bawake's companies include Vaishnavi Vijay Kolase (Carezie Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available